Holen Sie sich die Stockscreener-App
39.92
1.66%
0.65
Handel nachbörslich:
39.70
-0.22
-0.55%
Schlusskurs vom Vortag:
$39.27
Offen:
$39.34
24-Stunden-Volumen:
191.84K
Relative Volume:
0.42
Marktkapitalisierung:
$1.14B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.47M
KGV:
-7.132
EPS:
-5.5973
Netto-Cashflow:
$-73.92M
1W Leistung:
+4.50%
1M Leistung:
+36.11%
6M Leistung:
+85.59%
1J Leistung:
+61.49%
1-Tages-Spanne:
$38.92
$40.00
1-Wochen-Bereich:
$37.84
$40.35
52-Wochen-Spanne:
$16.54
$41.70
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Firmenname
Lenz Therapeutics Inc
Sektor
Branche
Telefon
858-925-7000
Adresse
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Vergleichen Sie LENZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
39.92 | 1.12B | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-14 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-03-18 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Outperform |
| 2024-08-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-04-10 | Eingeleitet | Citigroup | Buy |
| 2024-03-27 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-23 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-02-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | Herabstufung | Cowen | Outperform → Market Perform |
| 2023-01-25 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-06 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-04-14 | Eingeleitet | BTIG Research | Buy |
| 2022-03-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-07-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
What’s the beta of LENZ Therapeutics Inc. stockEarnings Risk Summary & Detailed Earnings Play Strategies - 더경남뉴스
What the charts say about LENZ Therapeutics Inc. todayJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
Can volume confirm reversal in LENZ Therapeutics Inc.2025 Short Interest & Risk Adjusted Swing Trade Ideas - Newser
Institutional scanner results for LENZ Therapeutics Inc.2025 Key Highlights & Technical Pattern Alert System - Newser
Lenz Therapeutics shares fall 1.17% premarket after presenting at Citi's Biopharma Back to School Conference. - AInvest
Backtesting results for LENZ Therapeutics Inc. trading strategiesEarnings Growth Summary & Weekly Market Pulse Updates - Newser
Will LENZ Therapeutics Inc. price bounce be sustainableJuly 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
Key metrics from LENZ Therapeutics Inc.’s quarterly data2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser
Analyzing LENZ Therapeutics Inc. with multi timeframe chartsM&A Rumor & Long-Term Safe Return Strategies - Newser
What momentum shifts mean for LENZ Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Trend analysis for LENZ Therapeutics Inc. this weekJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
What MACD signals say about LENZ Therapeutics Inc.July 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser
Should you hold or exit LENZ Therapeutics Inc. nowJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
LENZ Therapeutics: A Case Study in Strategic Execution and Market Readiness - AInvest
Transcript : LENZ Therapeutics, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 09 - MarketScreener
LENZ Therapeutics Inc. stock volume spike explainedJuly 2025 Trends & Community Consensus Picks - Newser
Can swing trading help recover from LENZ Therapeutics Inc. lossesM&A Rumor & Safe Entry Zone Identification - Newser
Will LENZ Therapeutics Inc. stock go up soonJuly 2025 Volume & Expert Approved Momentum Ideas - Newser
Will LENZ Therapeutics Inc. rebound enough to break evenJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysisWeekly Gains Summary & High Win Rate Trade Alerts - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio chartsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
How to manage a losing position in LENZ Therapeutics Inc.July 2025 Selloffs & Smart Investment Allocation Insights - Newser
Will LENZ Therapeutics Inc. stock recover after recent dropIndex Update & Free Growth Oriented Trading Recommendations - Newser
Will LENZ Therapeutics Inc. outperform during market rallies2025 Volatility Report & Weekly Watchlist for Consistent Profits - khodrobank.com
Can LENZ Therapeutics Inc. expand its profit marginsJobs Report & Fast Momentum Stock Entry Tips - khodrobank.com
Earnings visualization tools for LENZ Therapeutics Inc.Market Movers & Accurate Buy Signal Notifications - Newser
Real time social sentiment graph for LENZ Therapeutics Inc.Product Launch & Technical Buy Zone Confirmation - Newser
Pullback Watch: Is LENZ Therapeutics Inc. gaining market shareMarket Rally & Technical Confirmation Trade Alerts - khodrobank.com
Will LENZ Therapeutics Inc. benefit from government policyWeekly Trade Analysis & Real-Time Price Movement Reports - khodrobank.com
Why LENZ Therapeutics Inc. is moving todayWeekly Investment Report & Verified Stock Trade Ideas - Newser
What’s the profit margin of LENZ Therapeutics Inc.Gold Moves & Low Volatility Stock Suggestions - khodrobank.com
Multi factor analysis applied to LENZ Therapeutics Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - Newser
Real time breakdown of LENZ Therapeutics Inc. stock performanceTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Does LENZ Therapeutics Inc. outperform in volatile markets2025 Stock Rankings & AI Forecast Swing Trade Picks - khodrobank.com
What momentum shifts mean for LENZ Therapeutics IncWeekly Gains Report & Real-Time Volume Analysis - Newser
LENZ Therapeutics Inc. stock outlook for YEAR2025 Risk Factors & Safe Capital Allocation Plans - Newser
Will LENZ Therapeutics Inc. benefit from macro trendsNew Guidance & Free Technical Pattern Based Buy Signals - Newser
LENZ Therapeutics Inc.’s volatility index tracking explainedEarnings Risk Summary & Fast Entry High Yield Tips - Newser
Tick level data insight on LENZ Therapeutics Inc. volatility2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
LENZ Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - sisaissue.com
Full technical analysis of LENZ Therapeutics Inc. stockInflation Watch & Reliable Intraday Trade Plans - Newser
Finanzdaten der Lenz Therapeutics Inc-Aktie (LENZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lenz Therapeutics Inc-Aktie (LENZ) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
47,443 |
1,850,891 |
1,274,197 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
26,161 |
1,050,392 |
1,374,059 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
25,818 |
1,020,888 |
924,175 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
23,368 |
911,655 |
900,807 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
12,885 |
517,356 |
949,993 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
145,051 |
5,729,514 |
1,430,848 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
69,949 |
2,762,986 |
977,963 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
30,628 |
1,181,049 |
1,400,220 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 18 '25 |
Sale |
38.56 |
15,085 |
581,694 |
962,878 |
| Versant Venture Capital VI, L. | 10% Owner |
Jul 10 '25 |
Sale |
34.00 |
191,376 |
6,506,784 |
1,575,899 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):